DiMasi, Joseph A., ., & Grabowski, H. G. (2012). R&D Costs and Returns to New Drug Develoopment: A Review of the Evidence. In P. M. Danzon & S. Nicholson (Eds.), The Oxford Handbook of the Economics of the Biopharmaceutical Industry (pp. 22–46). New York, NY: OUP USA.

DiMasi, Joseph A., Christopher L., and H. G. Grabowski. “R&D Costs and Returns to New Drug Develoopment: A Review of the Evidence.” In The Oxford Handbook of the Economics of the Biopharmaceutical Industry, edited by Patricia M. Danzon and Sean Nicholson, 22–46. New York, NY: OUP USA, 2012.

DiMasi, Joseph A., Grabowski HG. R&D Costs and Returns to New Drug Develoopment: A Review of the Evidence. In: Danzon PM, Nicholson S, editors. The Oxford Handbook of the Economics of the Biopharmaceutical Industry. New York, NY: OUP USA; 2012. p. 22–46.

DiMasi, Joseph A., Christopher L., and H. G. Grabowski. “R&D Costs and Returns to New Drug Develoopment: A Review of the Evidence.” The Oxford Handbook of the Economics of the Biopharmaceutical Industry, edited by Patricia M. Danzon and Sean Nicholson, OUP USA, 2012, pp. 22–46.

DiMasi, Joseph A., Grabowski HG. R&D Costs and Returns to New Drug Develoopment: A Review of the Evidence. In: Danzon PM, Nicholson S, editors. The Oxford Handbook of the Economics of the Biopharmaceutical Industry. New York, NY: OUP USA; 2012. p. 22–46.